Christopher D. Andry, MPhil, PhD Hear my name
Professor
Boston University Chobanian & Avedisian School of Medicine
Pathology & Laboratory Medicine
Anatomic Pathology

PhD, Boston University
MPhil, Lancaster University
BSc, Lancaster University



Christopher Andry, MPhil, PhD, was named Chief, Department of Pathology and Laboratory Medicine at Boston Medical Center (BMC) and Chair, Department of Pathology and Laboratory Medicine at Chobanian and Avedisian School of Medicine (BUSM) effective September 1, 2019. Dr. Andry’s career at BMC and BU has spanned more than 40 years, during which he has demonstrated a deep-rooted commitment to and passion for the mission of the BMC Health System, BUSM and the Medical Campus, Boston University and the Boston community at large. As Chief and Chair, Dr. Andry will bring his clinical expertise and leadership to the role to ensure a high-quality, integrated, academic department that is innovative, well-resourced, and collaborative.

Dr. Andry is a member of the BU-BMC Cancer Center Executive Committee, and liaison to New England Donor Services.

Dr. Andry is well recognized in the field of biospecimen science. In a team-based setting at BU and BMC, he has established evidence-based protocols and standards to ensure curation and distribution of high-quality, well-annotated biospecimens. Dr. Andry has served as the PI on more than $2 million in NCI funded grants and contracts to set standards for the science of biospecimen collection. Dr. Andry has raised the profile of BU in biobanking and provides the expertise for obtaining usable tissue samples for medical campus research faculty. Dr Andry is focused on supporting research and infrastructure to reduce healthcare disparities for underserved populations and has an interest in cancer biology, specifically prostate and breast cancer.

Dr. Andry received his PhD in pathology from BUSM and his bachelor of science and master of philosophy in biological sciences from the University of Lancaster, United Kingdom. He has published and collaborated on more than 50 articles, reviews and medical texts.

Diversity, Equity, Inclusion and Accessibility

Our organizations BMC and Boston University Chobanian & Avedisian School of Medicine, as well as our department, have a rich history of diversity, equity and inclusion. However, we recognize that there is much work to be done to create a fair and just community and society.

We are committed to the active pursuit of equity and inclusion for our faculty, residents, students, and staff. We commit to the support of our local and regional community to create opportunities for employment and education. We support education about social determinants of health and embrace anti-racism.

Chair
Boston University Chobanian & Avedisian School of Medicine
Pathology & Laboratory Medicine


Chief
Boston University Chobanian & Avedisian School of Medicine
Pathology & Laboratory Medicine


Professor
Boston University Chobanian & Avedisian School of Medicine
Family Medicine


Member
Boston University
BU-BMC Cancer Center


Member
Boston University
Evans Center for Interdisciplinary Biomedical Research


Boston Medical Center


Graduate Faculty (Primary Mentor of Grad Students)
Boston University Chobanian & Avedisian School of Medicine, Graduate Medical Sciences




New England Centenarian Study
07/01/2016 - 06/30/2022 (Multi-PI)
PI: Christopher D. Andry, MPhil, PhD
The William M. Wood Foundation



Boston Medical Center Biospecimen Source Site for the Clinical Proteomic Tumor Analysis
09/17/2019 - 02/23/2021 (PI)
National Cancer Institute/NIH/DHHS

Thrombosis -Related Biomarkers in Cancer Patients and Pre-analytic Variables that May Impact Standardization
11/16/2016 - 04/30/2019 (PI)
Leidos Biomedical Research Inc.

caHUB at Boston Medical Center
01/01/2011 - 12/31/2016 (PI)
Leidos Biomedical Research Inc. NIH-NCI

NDRI-Tissue Source Site
05/01/2014 - 04/30/2016 (PI)
National Disease Research Interchange NIH-NCRR
U42 RR006042

caHUB BPV ST12-1098(2012)
11/01/2012 - 05/31/2015 (PI)
Leidos Biomedical Research Inc. NIH-NCI

The Cancer Genome Atlas Project (TCGA)
05/09/2013 - 12/31/2014 (PI)
Leidos Biomedical Research Inc. NIH-NCI

Mammograms in Action Breast Health Care Grant
04/01/2012 - 03/29/2013 (PI)
Susan G. Komen for the Cure

Prostate Cancer Screening Informed Decision Making
04/09/2012 - 06/29/2012 (PI)
DPH CDC

Here to Help Advocacy Program
10/01/2006 - 09/30/2007 (PI)
Mass. Developmental Disabilities Council

Here to Help / Disability Advocacy Program
10/01/2004 - 09/30/2005 (PI)
The Agnes M Lindsay Trust

Showing 10 of 11 results. Show All Results

Title


Yr Title Project-Sub Proj Pubs
2019 BOSTON MEDICAL CENTER:1106016 [18-066657] 261201600011I-P00002-26100004-1
2019 EXERCISE OPTION PERIOD 1 AND FUND ADDITIONAL CASES FOR PAYMENTS 1-3. 261201600011I-P00001-26100003-1

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Dodge MC, Ye L, Duffy ER, Cole M, Gawel SH, Werler MM, Daghfal D, Andry C, Kataria Y. Kinetics of SARS-CoV-2 Serum Antibodies Through the Alpha, Delta, and Omicron Surges Among Vaccinated Health Care Workers at a Boston Hospital. Open Forum Infect Dis. 2023 Jul; 10(7):ofad266.View Related Profiles. PMID: 37396669; PMCID: PMC10314714; DOI: 10.1093/ofid/ofad266;
     
  2. Ragan EJ, McCallum C, Marathe J, Cole M, Hofman M, Henderson AJ, Flack T, Miller NS, Burks EJ, Zhao GQ, Denis R, Lin NH, Jacobson KR, Andry CD, Pelton SI, Duffy ER, Bhadelia N. Pandemic Response Requires Research Samples: A U.S. Safety-Net Hospital's Experience and Call for National Action. Ann Intern Med. 2021 12; 174(12):1727-1732.View Related Profiles. PMID: 34724402; PMCID: PMC11234338; DOI: 10.7326/M21-2857;
     
  3. Song J, Korunes-Miller J, Banerji R, Wu Y, Fazeli S, Zheng H, Orr B, Morgan E, Andry C, Henderson J, Miller NS, White A, Grinstaff MW. On-Site, On-Demand 3D-Printed Nasopharyngeal Swabs to Improve the Access of Coronavirus Disease-19 Testing. Glob Chall. 2021 Nov; 5(11):2100039.View Related Profiles. PMID: 34754507; PMCID: PMC8562062; DOI: 10.1002/gch2.202100039;
     
  4. Kataria Y, Cole M, Duffy E, de la Cena K, Schechter-Perkins EM, Bouton TC, Werler MM, Pierre C, Ragan EJ, Weber SE, Jacobson KR, Andry C. Seroprevalence of SARS-CoV-2 IgG antibodies and risk factors in health care workers at an academic medical center in Boston, Massachusetts. Sci Rep. 2021 05 06; 11(1):9694.View Related Profiles. PMID: 33958668; PMCID: PMC8102593; DOI: 10.1038/s41598-021-89107-5;
     
  5. Giadone RM, Mithal A, Miller GJ, Matte TM, Yeung AK, Dowrey TW, Werder RB, Miller NS, Andry CD, Vanuytsel K, Murphy GJ. qRT-PCR Platforms for Diagnosing and Reporting SARS-CoV-2 Infection in Human Samples. STAR Protoc. 2020 Sep 18; 1(2):100102.View Related Profiles. PMID: 32954369; PMCID: PMC7490627; DOI: 10.1016/j.xpro.2020.100102;
     
  6. Selby R, Duffy ER, Berny-Lang MA, Andry CD, Lee AYY. Impact of specific preclinical variables on coagulation biomarkers in cancer-associated thrombosis. Thromb Res. 2020 07; 191 Suppl 1:S26-S30.View Related Profiles. PMID: 32736774
     
  7. Vanuytsel K, Mithal A, Giadone RM, Yeung AK, Matte TM, Dowrey TW, Werder RB, Miller GJ, Miller NS, Andry CD, Murphy GJ. Rapid Implementation of a SARS-CoV-2 Diagnostic Quantitative Real-Time PCR Test with Emergency Use Authorization at a Large Academic Safety Net Hospital. Med (N Y). 2020 Dec 18; 1(1):152-157.e3.View Related Profiles. PMID: 32838351; PMCID: PMC7235561; DOI: 10.1016/j.medj.2020.05.001;
     
  8. Belghasem M, Roth D, Richards S, Napolene MA, Walker J, Yin W, Arinze N, Lyle C, Spencer C, Francis JM, Thompson C, Andry C, Whelan SA, Lee N, Ravid K, Chitalia VC. Metabolites in a mouse cancer model enhance venous thrombogenicity through the aryl hydrocarbon receptor-tissue factor axis. Blood. 2019 12 26; 134(26):2399-2413.View Related Profiles. PMID: 31877217; PMCID: PMC6933294; DOI: 10.1182/blood.2019001675;
     
  9. Calner P, Sperring H, Ruiz-Mercado G, Miller NS, Andry C, Battisti L, Scrudder K, Shea F, Chan A, Schechter-Perkins EM. HCV screening, linkage to care, and treatment patterns at different sites across one academic medical center. PLoS One. 2019; 14(7):e0218388.View Related Profiles. PMID: 31291275; PMCID: PMC6619669; DOI: 10.1371/journal.pone.0218388;
     
  10. Feng F, Thompson MP, Thomas BE, Duffy ER, Kim J, Kurosawa S, Tashjian JY, Wei Y, Andry C, Stearns-Kurosawa DJ. A computational solution to improve biomarker reproducibility during long-term projects. PLoS One. 2019; 14(4):e0209060.View Related Profiles. PMID: 30995241; PMCID: PMC6469750; DOI: 10.1371/journal.pone.0209060;
     
Showing 10 of 32 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 32 publications over 18 distinct years, with a maximum of 4 publications in 2019

YearPublications
19902
19941
19972
19981
19991
20002
20011
20031
20052
20062
20072
20092
20171
20181
20194
20203
20213
20231


Charles River, Medical Campus Faculty Promoted to Full Professor

BU Today 2/11/2019
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Death
Laboratory
Management
Operations
Organ
Pathology

Available to Mentor as: (Review Mentor Role Definitions):
  • Career Mentor
  • Project Mentor
Contact for Mentoring:
  • Email (see 'Contact Info')

670 Albany St Biosquare III
Boston MA 02118
Google Map

617.358.2929
Download vCard

Andry's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (223) concept(s)
_
Media Mentions
_
Co-Authors
See all (44) people
_
Similar People
See all (60) people
_
Same Department
Search Department